Status:
UNKNOWN
Eliminate Hepatitis C/EC Partnership Evaluation Protocol
Lead Sponsor:
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Collaborating Sponsors:
Burnet Institute
The Alfred
Conditions:
Hepatitis C
Chronic Hepatitis c
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Eliminate Hepatitis C (EC) Partnership project is a multi-site, multi-year project aiming to enhance and extend hepatitis C virus (HCV) care and treatment among people who inject drugs (PWID) thro...
Detailed Description
An estimated 71 million people are living with hepatitis C virus (HCV) world-wide, at significant risk of morbidity and mortality from liver cirrhosis, liver failure and hepatocellular carcinoma. Howe...
Eligibility Criteria
Inclusion
- The level of recruitment is clinics rather than individuals. Eligible clinics are those with a high HCV caseload, with a focus on drug and alcohol community clinics and general practitioners.
- Eligibility criteria for individuals providing information in the form of interviews will be:
- 18 years of age or older; AND
- Willing and able to provide informed, written consent to participate; AND
- Either of:
- staff of a participating EC site who are involved in hepatitis C care; OR
- clients of a participating EC site who attend the site for screening and management of hepatitis C.
Exclusion
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04061551
Start Date
December 1 2016
End Date
December 31 2021
Last Update
August 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Burnet Institute
Melbourne, Victoria, Australia, 3004